Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in
elderly people globally. It is estimated that there will be more Asians with AMD than the rest …

Background: Polypoidal choroidal vasculopathy (PCV) is an exudative maculopathy
affecting vision, with clinical features distinct from neovascular age-related macular …

Age related macular degeneration (AMD) in Asians has been suggested to differ from their
Western counterparts in terms of epidemiology, pathogenesis, clinical presentation and …

Purpose: To evaluate the 3-year outcome in eyes with polypoidal choroidal vasculopathy
(PCV) treated with photodynamic therapy with verteporfin. Methods: Retrospective study and …

Topic A systematic review and meta-analysis of the genetic association with polypoidal
choroidal vasculopathy (PCV) and the genetic difference between PCV and neovascular …

Purpose To investigate the association of all reported common polymorphisms in anti‐
vascular endothelial growth factor (VEGF) therapy response and to identify potential …

Polypoidal choroidal vasculopathy (PCV) is a subtype of neovascular age-related macular
degeneration (nAMD), commonly seen in the Asian population. It is dissimilar in …

Purpose To investigate the genetic associations of polypoidal choroidal vasculopathy (PCV),
the genetic difference between PCV and age-related macular degeneration (AMD), and the …

Anti-vascular endothelial growth factor (anti-VEGF) therapies for neovascular age-related
macular degeneration (nAMD) have proven efficacy at a study-population level, although …

Polypoidal choroidal vasculopathy (PCV) is usually regarded as a subtype of choroidal
neovascularization (CNV) that is secondary to age-related macular degeneration (AMD) …